54
Participants
Start Date
September 10, 2021
Primary Completion Date
October 6, 2023
Study Completion Date
October 6, 2023
Etrasimod
Etrasimod tablet by mouth, once daily for 12 weeks
Etrasimod
Etrasimod tablet by mouth, once daily for 12 weeks
Placebo
Etrasimod matching placebo tablet by mouth, once daily up to 12 weeks
Aichi Medical University Hospital, Nagakute
Kojunkai Daido Clinic, Nagoya
Kojunkai Daido Hospital, Nagoya
Nagoya City University Hospital, Nagoya
Fujita Health University Hospital, Toyoake
Toyohashi Municipal Hospital, Toyohashi
NHO Hirosaki General Medical Center, Hirosaki-shi
Hirosaki University Hospital(OCT/PFT/DLCO), Hirosaki-shi
Hirosaki University Hospital, Hirosaki-shi
Tsujinaka Hospital Kashiwanoha, Kashiwa-shi
Ishii Eye Clinic, Nagareyama-shi
Toho University Sakura Medical Center, Sakura
Saiseikai Matsuyama Hospital, Matsuyama
Ehime University Hospital, Toon-shi
Fukuoka University Hospital, Fukuoka
Japan Community Health Care Organization Kyushu Hospital, Kitakyushu
Kokura Memorial Hospital, Kitakyushu-shi
Kokura Memorial Hospital, Kutakyushu-shi
Kitakyushu Municipal Medical Center, Kitakyushu-shi
Koyanose Eye Clinic, Kitakyushu-shi
Our Lady of the Snow St. Mary's Hospital, Kurume
Kurume University Hospital, Kurume-shi
Fukuoka Shinmizumaki Hospital, Onga-gun
Gifu University Hospital, Gifu
SUBARU Health Insurance Society Ota Memorial Hospital, Ota-shi
Nakayama EYE Clinic, Fukuyama-shi
NHO Fukuyama Medical Center, Fukuyama-shi
Hiroshima University Hospital, Hiroshima
Asahikawa City Hospital, Asahikawa-shi
Tokushukai Sapporo Tokushukai Hospital, Sapporo
Sapporo-Kosei General Hospital, Sapporo
NHO Mito Medical Center, Higashiibaraki-gun
Yuai Memorial Hospital, Koga-shi
Ibaraki Seinan Medical Center Hospital, Sashima-gun
Matsumoto Eye Clinic, Toride-shi
Tsuchiura Kyodo General Hospital, Tsuchiura-shi
NHO Kanazawa Medical Center, Kanazawa
Kudo Internist Heart Clinic, Morioka
Iwate Medical University Uchimaru Medical Center, Morioka
Takamatsu Red Cross Hospital, Takamatsu
JA- Kagoshima Koseiren Hospital (PET/DLCO), Kagoshima
Clinical Pathology Laboratory (Diagnostick center), Kagoshima
Sameshima Eye Clinic (OCT), Kagoshima
Sameshima Hospital, Kagoshima
Sagamihara Kyodo Hospital, Sagamihara
Social Welfare Organization Imperial Gift Foundation,Inc.Saiseikai Yokohamashi Nanbu Hospital, Yokohama
NHO Yokohama Medical Center, Yokohama
Japanese Red Cross Kumamoto Hospital, Kumamoto
University Hospital Kyoto Prefectural University of Medicine, Kyoto
National Hospital Organization Kyoto Medical Center, Kyoto
Mie University Hospital, Tsu
Hinaga Nishi Ophthalmology Clinic, Yokkaichi- Shi
Mie Prefectural General Medical Center, Yokkaichi-shi
Tohoku University Hospital, Sendai
JOHAS Tohoku Rosai Hospital, Sendai
Nagaoka Red Cross Hospital, Nagaoka-shi
Kansai Medical University Hospital, Hirakata-shi
Medical Corporation Tokushukai Kishiwada Tokushukai Hospital, Kishiwada-shi
Osaka City University Hospital, Osaka
Japan Community Health care Organization Osaka Hospital, Osaka
Osaka Medical and Pharmaceutical University Hospital, Takatsuki
Saga University Hospital, Saga
Saitama Medical University Hospital, Iruma-gun
Japan Community Health care Organization Saitama Medical Center, Saitama-shi
Shiga University of Medical Science Hospital, Ōtsu
Hamamatsu University Hospital, Hamamatsu
Matsuda Hospital, Hamamatsu
Hamamatsu Medical Centre, Hamamatsu
Tokyo Medical and Dental University Hospital, Bunkyo-ku
Tokai University Hachioji Hospital, Hachiōji
Showa General Hospital, Kodaira-shi
Kitasato University Kitasato Institute Hospital, Minato-ku
JCHO Tokyo Yamate Medical Center, Shinjuku-ku
Wakayama Medical University Hospital, Wakayama
Yamanashi Prefectural Central Hospital, Kofu
Fukushima Medical University Hospital, Fukushima
Kagoshima University Hospital, Kagoshima
NHO Osaka National Hospital, Osaka
Osaka National Hospital Institutional Review Board, Osaka
Teikyo University Hospital, Tokyo
Lead Sponsor
Arena is a wholly owned subsidiary of Pfizer
INDUSTRY
Pfizer
INDUSTRY